Novo Nordisk A/S (NVO)
69.48
-0.09 -0.13%
NYSE
Sep 18, 16:59
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 18.75B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.602 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.136B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 84.10% |
| Profit Margin (Quarterly) | 35.41% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 1.87% |
| Price and Valuation | |
| Market Cap | 161.68B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.737 |
| PE Ratio | 26.70 |
| Price to Book Value | 17.85 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.069 |
| Free Cash Flow (Quarterly) | 3.381B |
| Return on Equity | Upgrade |
View All NVO News
News
-
WireHeadlineTime (ET)
-
Yahoo09/18 15:14
-
Yahoo09/18 11:40
-
MT Newswires09/17 11:06
-
Yahoo09/16 22:19
-
Yahoo09/14 04:59
-
Yahoo09/07 08:02
-
SA Breaking News09/01 10:25
-
Yahoo08/31 09:03
-
Yahoo08/26 15:38
-
Yahoo08/24 09:24
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/05/2021 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results in 2020 |
| 10/30/2020 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results for 2020 |
| 08/14/2020 | Dividends | Amount: 0.5178, Declared Date: Aug 01 2020, Pay Date: Aug 25 2020 |
| 08/06/2020 | Earnings | Novo Nordisk A/S Second Quarter Earnings Results for 2020 |
| 05/06/2020 | Earnings | Novo Nordisk A/S First Quarter Earnings Results for 2020 |
| 03/27/2020 | Dividends | Amount: 0.7826, Declared Date: Feb 06 2020, Pay Date: Apr 07 2020 |
| 03/26/2020 14:00 CET | Misc | Novo Nordisk A/S Annual General Meeting for 2019 |
| 02/05/2020 | Earnings | Novo Nordisk A/S Fourth Quarter Earnings Results for 2019 |
| 02/05/2020 | Misc | Novo Nordisk A/S Annual Report for 2019 |
| 11/01/2019 | Earnings | Novo Nordisk A/S Third Quarter Earnings Results in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.novonordisk.com
- Investor Relations URL: http://www.novonordisk.com/investors.html
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Growth
- Next Earnings Release: Oct. 30, 2020
- Last Earnings Release: Aug. 06, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Aug. 14, 2020
- Description: With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 69.48 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| 0P0001F515 | BMO Concentrated Global Equity Adv | 4.98% |
| LIFE.TO | Evolve Global Healthcare Enh Yld ETF Hdg | 4.66% |
| PPH | VanEck Vectors Pharmaceutical ETF | 4.62% |
| 0P0001F517 | BMO European F | 4.01% |
| AMIGX | Amana Growth Institutional | 2.60% |
| PHLQX | PGIM Jennison Health Sciences R6 | 2.46% |
| LGGBX | ClearBridge International Growth A2 | 1.94% |
| DGYGX | BNY Mellon Appreciation Y | 1.65% |
| THW | Tekla World Healthcare | 1.61% |
| JTD | Nuveen Tax-Adv Div Growth | 1.47% |
| CHW | Calamos Global Dynamic Income | 1.14% |
| FVD | First Trust Value Line® Dividend ETF | 0.59% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NVO Tweets Stocktwits
Advertisement
